Abstract
This TriMark Publications report examines the disposable syringe markets as
well as the supplies utilized in clinics and by patients directly in their
homes to diagnose and monitor disease and to administer medications. This
analysis is intended to provide basic market data pertaining to the U.S. and
worldwide market segments. Each market segment is analyzed to determine size,
growth rates, sales projections and factors influencing growth in the U.S. and
internationally. Unit and dollar volume are used to indicate market sizes.
Additionally, this review examines industry challenges and potential threats
to syringe and needle supplies manufacturers and makes strategic
recommendations for boosting market share. The emphasis is on those companies
actively developing and marketing products to hospitals, physicians and the
general public for medically related uses. The disposable syringe market
segments are identified as: 1) total reusable needle and syringe market; 2)
total disposable needle and syringe market; 3) prefilled syringes; 4) safety
syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination
injectors; 8) blood collection needles and syringes; 9) hypodermic needles and
syringes market; 10) insulin needles and syringes market; 11) specialty
needles and syringes market; and 12) needleless injector market.
Methodology
The author of this report has a Ph.D. with over 40 years of consulting
experience. He has written over 1,000 articles, and has published four books.
The editor holds a Ph.D. and is a retired college professor with vast
experience in biochemistry, biotechnology, pharmacology and environmental
biology. Company-specific information is obtained mainly from industry trade
publications, academic journals, news and research articles, press releases
and corporate websites, as well as annual reports for publicly-held firms.
Additionally, sources of information include the nongovernmental organizations
(NGOs) such as the World Health Organization (WHO) and governmental entities
like the U.S. Department of Health and Human Services (HHS) and U.S. federal
agencies such as the National Institutes of Health (NIH), the Food and Drug
Administration (FDA) and the Centers for Disease Control and Prevention (CDC).
Where possible and practicable, the most recent data available have been used.
| 
View Cart
